BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17493435)

  • 21. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome.
    Sato H; Minagawa M; Sasaki N; Sugihara S; Kazukawa I; Minamitani K; Wataki K; Konda S; Inomata H; Sanayama K; Kohno Y
    J Pediatr Endocrinol Metab; 2011; 24(5-6):257-63. PubMed ID: 21823520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden onset agranulocytosis and hepatotoxicity after taking methimazole.
    Yang J; Zhong J; Zhou LZ; Hong T; Xiao XH; Wen GB
    Intern Med; 2012; 51(16):2189-92. PubMed ID: 22892501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholestatic hepatitis in a patient with Graves' disease resolved with total thyroidectomy.
    Abdel Khalek M; Abd ElMageed Z; Khan A; Broussard G; Kandil E
    Trop Gastroenterol; 2011; 32(4):328-30. PubMed ID: 22696919
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].
    Lehtihet M; Zedenius J; Helldén A; Axelsson R; Calissendorff J
    Lakartidningen; 2009 Oct 7-13; 106(41):2607-8, 2610-1. PubMed ID: 19927925
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased risk for thionamide-induced agranulocytosis in elderly patients: a case presentation and literature review.
    Bukhari S; Khan M; Kumar N; Mohan V
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28716776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Migratory polyarthritis as an adverse effect of thiamazole use in a 13-year-old girl with Graves' disease.
    Janson JA; de Laat P; Draaisma JM
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1169-71. PubMed ID: 25968432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithyroid drugs.
    Cooper DS
    N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
    Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
    Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.
    Bahn RS; Burch HS; Cooper DS; Garber JR; Greenlee CM; Klein IL; Laurberg P; McDougall IR; Rivkees SA; Ross D; Sosa JA; Stan MN
    Thyroid; 2009 Jul; 19(7):673-4. PubMed ID: 19583480
    [No Abstract]   [Full Text] [Related]  

  • 31. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Kidney Injury Following Methimazole Initiation: A Case Report.
    Shell A; Sullivan JW
    J Pharm Pract; 2020 Feb; 33(1):99-101. PubMed ID: 30111225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methimazole-induced cholestatic hepatitis: two cases report and literature review.
    Zou H; Jin L; Wang LR; Braddock M; Cai WW; Zheng MH
    Oncotarget; 2016 Jan; 7(4):5088-91. PubMed ID: 26498145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
    Kallner G; Vitols S; Ljunggren JG
    J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
    Suzuki N; Noh JY; Hiruma M; Kawaguchi A; Morisaki M; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Iwaku K; Yoshihara A; Watanabe N; Sugino K; Ito K
    Thyroid; 2019 Oct; 29(10):1390-1398. PubMed ID: 31573408
    [No Abstract]   [Full Text] [Related]  

  • 36. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
    Rivkees SA; Szarfman A
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Liver Failure: A Potential Complication of Antithyroid Medication Use.
    Chou C; Wong RJ; Higgins JP; Perumpail RB; Ahmed A
    Dig Dis Sci; 2015 Jul; 60(7):1924-7. PubMed ID: 25366145
    [No Abstract]   [Full Text] [Related]  

  • 38. Remission after potassium iodide therapy in patients with Graves' hyperthyroidism exhibiting thionamide-associated side effects.
    Okamura K; Sato K; Fujikawa M; Bandai S; Ikenoue H; Kitazono T
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3995-4002. PubMed ID: 25144628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute toxic hepatitis induced by methimazole: two cases].
    Alvarez MP; Cano RL; Fernández CP; Méndez LF; García RG
    Endocrinol Nutr; 2010 Nov; 57(9):451-3. PubMed ID: 20675204
    [No Abstract]   [Full Text] [Related]  

  • 40. Current trends in antithyroid drug treatment of Graves' disease.
    Okosieme OE; Lazarus JH
    Expert Opin Pharmacother; 2016 Oct; 17(15):2005-17. PubMed ID: 27615550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.